His body naturally produces alcohol, he is acquitted after a drunk driving conviction
Who is David Pecker, the first key witness in Donald Trump's trial?
What does the law on the expulsion of migrants to Rwanda adopted by the British Parliament contain?
The shadow of Chinese espionage hangs over Westminster
Colorectal cancer: what to watch out for in those under 50
H5N1 virus: traces detected in pasteurized milk in the United States
What High Blood Pressure Does to Your Body (And Why It Should Be Treated)
Vaccination in France has progressed in 2023, rejoices Public Health France
The right deplores a “dismal agreement” on the end of careers at the SNCF
The United States pushes TikTok towards the exit
Air traffic controllers strike: 75% of flights canceled at Orly on Thursday, 65% at Roissy and Marseille
This is what your pay slip could look like tomorrow according to Bruno Le Maire
Sky Dome 2123, Challengers, Back to Black... Films to watch or avoid this week
The standoff between the organizers of Vieilles Charrues and the elected officials of Carhaix threatens the festival
Strasbourg inaugurates a year of celebrations and debates as World Book Capital
Kendji Girac is “out of the woods” after his gunshot wound to the chest
Skoda Kodiaq 2024: a 'beast' plug-in hybrid SUV
Tesla launches a new Model Y with 600 km of autonomy at a "more accessible price"
The 10 best-selling cars in March 2024 in Spain: sales fall due to Easter
A private jet company buys more than 100 flying cars
This is how housing prices have changed in Spain in the last decade
The home mortgage firm drops 10% in January and interest soars to 3.46%
The jewel of the Rocío de Nagüeles urbanization: a dream villa in Marbella
Rental prices grow by 7.3% in February: where does it go up and where does it go down?
Europeans: “All those who claim that we don’t need Europe are liars”, criticizes Bayrou
With the promise of a “real burst of authority”, Gabriel Attal provokes the ire of the opposition
Europeans: the schedule of debates to follow between now and June 9
Europeans: “In France, there is a left and there is a right,” assures Bellamy
These French cities that will boycott the World Cup in Qatar
NBA: the Wolves escape against the Suns, Indiana unfolds and the Clippers defeated
Real Madrid: what position will Mbappé play? The answer is known
Cycling: Quintana will appear at the Giro
Premier League: “The team has given up”, notes Mauricio Pochettino after Arsenal’s card
the ROME – Not as an act of charity but a real change, capable of transforming some life-saving drugs from luxury goods into the treatments accessible and affordable, push the pharmaceutical industry to invest in medicinal products deemed to be less profitable. It is the wish for 2020 of Doctors Without Borders (MSF), formulated in 5 different wishes regarding Tuberculosis resistant to drugs, insulin, HIV, pneumonia and Ebola, enclosed from the common and biggest hope that all the people of the world are able to receive the care they need.
Tuberculosis.
best Treatment available for all . Thirty years ago, when MSF started to treat people with tuberculosis resistant to the drugs, there were in circulation only the old drugs ineffective, causing serious side effects to patients. Today, after years of awareness-raising campaigns alongside the global community to the TB, we care better and safer for the people suffering from tuberculosis resistant to the drugs even if the pharmaceutical companies have imposed such a high price on individual medicinal products to make them too expensive for those who need it. These drugs were not developed by sun pharmaceutical companies: they are the result of years of work by researchers, clinicians and health professionals, mainly financed with public funds. However, policies on pricing and access to drugs remain under the control of the pharmaceutical companies that leave many people suffering from tuberculosis are excluded from life-saving treatment. In 2020, as members of the global community to the TB, we want to claim the right to have a say on who has access to the new treatments for tuberculosis.
Insulin
A drug that must be made accessible again. scientists have discovered the insulin a hundred years ago received the Nobel Prize for medicine for their discovery, but also for their choice to sell the rights to the drug to only 1 dollar, in the spirit of making the treatment accessible to all those who had need. But in the course of the last century, three companies control almost exclusively the market of the insulin and, in abuse of their monopoly position, they have increased the prices in some countries, year after year. Today, more than half of the people who need the drug fails in practice to benefit. In 2020, we hope to see other manufacturers can provide insulin of quality at the most affordable prices. We also need to find new ways to make accessible to our patients and innovative solutions for the use of insulin, such as pens, insulin. These are tools that make a huge difference in the lives of the people.
HIV.
Are drugs for pediatric patients. Twenty years ago, people in developing countries were dying of AIDS because they were not able to pay up to $ 10,000 a year for the necessary treatment (video-animation on HIV). The team of MSF, determined to fight this injustice, they used all means possible to ensure the drugs to the people. Today, almost 25 million people live with HIV in good health and follow a cure at a price of only 65 dollars a year. But children with HIV have been forgotten: there is no commercial incentive for pharmaceutical companies to invest specifically in the treatment of pediatric, from the moment in which the young patients infected with hiv live in developing countries where you cannot afford the purchase of medicines so dear. The result is that children born with HIV in the communities where we work MSF does not have access to the care they would need. In 2020, the MSF will continue to put pressure on the pharmaceutical industry, which puts profits before people when it comes to investing in new drugs, to treat children more effectively, with combined treatments adapted specifically to their needs.
Pneumonia
Vaccine accessible to children all over the world. Every 39 seconds a child dies of pneumonia, despite there being an effective vaccine against this dangerous and deadly disease (video-animation, pneumonia). A time that is inaccessible in many developing countries, today the vaccine is distributed in the poorer countries thanks to donor financing. Millions of children who live in middle-income countries do not have access to vaccination because it is economically out of the reach of these were considered to be not "sufficiently poor" to receive funding. These are children dying for a preventable illness just because their countries can't afford to buy the vaccine. In 2020, we would like to see deleted this terrible injustice and unnecessary suffering. The new vaccine manufacturers of developing countries, who have created versions more cost-effective, they must be supported to ensure that the vaccine is provided to governments all over the world, and we can save more lives.
Ebola
Treatments and vaccines for the people who need it. for about forty years, Ebola (video animation on Ebola) is a deadly disease, but in spite of this for a long time was ignored by the manufacturers of the drugs that have considered the development of vaccines or treatments to fight the virus are not commercially advantageous. The epidemic in west Africa in 2014 has changed the scenario: what before had been considered by wealthy countries as a “problem” relating to only some areas of Africa, had assumed the dimension of a global threat. This has prompted the international community to move, and so today there are treatments and vaccines already available or coming soon. In 2020, the MSF will work to ensure that people in the countries most at risk timely access to new medicines and vaccines at an affordable price. These products are born through a considerable research and development effort on the part of multiple actors, funded almost entirely through public funding and not private investment. That's why we believe that we have a say on who has access to these treatments.
The main challenges. The access to treatment for HIV and TB, as well as the dissemination of the vaccine against the Ebola, are among the main challenges of the Campaign for Access to Medicines MSF since 1999, and it acts to break down the barriers to political, economic and legal, that prevent people from receiving the treatments they need. More information.
Tuberculosis.
best Treatment available for all . Thirty years ago, when MSF started to treat people with tuberculosis resistant to the drugs, there were in circulation only the old drugs ineffective, causing serious side effects to patients. Today, after years of awareness-raising campaigns alongside the global community to the TB, we care better and safer for the people suffering from tuberculosis resistant to the drugs even if the pharmaceutical companies have imposed such a high price on individual medicinal products to make them too expensive for those who need it. These drugs were not developed by sun pharmaceutical companies: they are the result of years of work by researchers, clinicians and health professionals, mainly financed with public funds. However, policies on pricing and access to drugs remain under the control of the pharmaceutical companies that leave many people suffering from tuberculosis are excluded from life-saving treatment. In 2020, as members of the global community to the TB, we want to claim the right to have a say on who has access to the new treatments for tuberculosis.
Insulin
A drug that must be made accessible again. scientists have discovered the insulin a hundred years ago received the Nobel Prize for medicine for their discovery, but also for their choice to sell the rights to the drug to only 1 dollar, in the spirit of making the treatment accessible to all those who had need. But in the course of the last century, three companies control almost exclusively the market of the insulin and, in abuse of their monopoly position, they have increased the prices in some countries, year after year. Today, more than half of the people who need the drug fails in practice to benefit. In 2020, we hope to see other manufacturers can provide insulin of quality at the most affordable prices. We also need to find new ways to make accessible to our patients and innovative solutions for the use of insulin, such as pens, insulin. These are tools that make a huge difference in the lives of the people.
HIV.
Are drugs for pediatric patients. Twenty years ago, people in developing countries were dying of AIDS because they were not able to pay up to $ 10,000 a year for the necessary treatment (video-animation on HIV). The team of MSF, determined to fight this injustice, they used all means possible to ensure the drugs to the people. Today, almost 25 million people live with HIV in good health and follow a cure at a price of only 65 dollars a year. But children with HIV have been forgotten: there is no commercial incentive for pharmaceutical companies to invest specifically in the treatment of pediatric, from the moment in which the young patients infected with hiv live in developing countries where you cannot afford the purchase of medicines so dear. The result is that children born with HIV in the communities where we work MSF does not have access to the care they would need. In 2020, the MSF will continue to put pressure on the pharmaceutical industry, which puts profits before people when it comes to investing in new drugs, to treat children more effectively, with combined treatments adapted specifically to their needs.
Pneumonia
Vaccine accessible to children all over the world. Every 39 seconds a child dies of pneumonia, despite there being an effective vaccine against this dangerous and deadly disease (video-animation, pneumonia). A time that is inaccessible in many developing countries, today the vaccine is distributed in the poorer countries thanks to donor financing. Millions of children who live in middle-income countries do not have access to vaccination because it is economically out of the reach of these were considered to be not "sufficiently poor" to receive funding. These are children dying for a preventable illness just because their countries can't afford to buy the vaccine. In 2020, we would like to see deleted this terrible injustice and unnecessary suffering. The new vaccine manufacturers of developing countries, who have created versions more cost-effective, they must be supported to ensure that the vaccine is provided to governments all over the world, and we can save more lives.
Ebola
Treatments and vaccines for the people who need it. for about forty years, Ebola (video animation on Ebola) is a deadly disease, but in spite of this for a long time was ignored by the manufacturers of the drugs that have considered the development of vaccines or treatments to fight the virus are not commercially advantageous. The epidemic in west Africa in 2014 has changed the scenario: what before had been considered by wealthy countries as a “problem” relating to only some areas of Africa, had assumed the dimension of a global threat. This has prompted the international community to move, and so today there are treatments and vaccines already available or coming soon. In 2020, the MSF will work to ensure that people in the countries most at risk timely access to new medicines and vaccines at an affordable price. These products are born through a considerable research and development effort on the part of multiple actors, funded almost entirely through public funding and not private investment. That's why we believe that we have a say on who has access to these treatments.
The main challenges. The access to treatment for HIV and TB, as well as the dissemination of the vaccine against the Ebola, are among the main challenges of the Campaign for Access to Medicines MSF since 1999, and it acts to break down the barriers to political, economic and legal, that prevent people from receiving the treatments they need. More information.
"The Republic will fight always in defense of the freedom of information, to its readers and to all those who have at heart the principles of democracy and civil coexistence"
Carlo Verdelli SUBSCRIBERS TO REPUBLIC © Reproduction reserved Today on The nightmare of a new war Because Trump has decided to kill Soleimani That missile to 1.45 in the morning that woke up Baghdad and the winds of war, Americans in the viewfinder and boundaries in alarm. The fuse is on what changes in the world after the killing of Soleimanithe Republic
